Type 2 Diabetes Connect
  • Saved

made a Post

Advancing oral treatment for Type 2 diabetes

Your obese type 2 diabetes patient, who is 58 years old, has been on metformin, but recent HbA1C levels are around 8.2%, despite attempts at controlling diet and exercise. The patient realizes something must be done and would very much like to maximize A1C reductions with the next option, hoping to achieve levels closer to a goal of 7.0%, if not below that, to avoid having to add multiple further medications. However, the patient hopes to avoid injectable medications if they are not completely necessary. The patient would also like to lose weight.

What medication would you recommend next?

Would your recommendation differ if the patient had a history of atherosclerotic cardiovascular disease?

How would you help this patient stay compliant with your prescribed treatment regimen?

  • 5yr
    Consider adding Glimepiride to the Metformin
  • 5yr
    Consider adding Glimepiride to the Metformin

Show More Comments

  • Saved

Comparison of patient- and clinician-reported outcome measures in lower back rehabilitation: introducing a new integrated performance measure (t2D)

Comparison of patient- and clinician-reported outcome measures in lower back rehabilitation: introducing a new integrated performance measure (t2D)

Source : https://link.springer.com/article/10.1007/s11136-021-02905-2

Purpose Patient- and clinician-reported outcome measures (PROMs, CROMs) are used in rehabilitation to evaluate and track the patient's health status and recovery. However, controversy still exists regarding their relevance and...

  • Saved

Research shows resistance training can help reduce type 2 diabetes risk

Research shows resistance training can help reduce type 2 diabetes risk

Source : https://medicalxpress.com/news/2021-06-resistance-diabetes.html

A group of Oakland University researchers used data from medical studies around the world to examine the impact of resistance training on type 2 diabetes risk.

  • Saved

Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis - PubMed

Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34135030/

1 Melbourne EpiCentre, University of Melbourne and Melbourne Health, Parkville, Victoria, Australia [email protected]. 2 Melbourne EpiCentre, University of Melbourne and Melbourne Health, Parkville, Victoria, Australia. 3 Pharmaceuticals Division, Genentech, South...

  • Saved

Association of Granuloma Annulare With Type 2 Diabetes, Hyperlipidemia, Autoimmune Disorders, and Hematologic Malignant Neoplasms - PubMed

Association of Granuloma Annulare With Type 2 Diabetes, Hyperlipidemia, Autoimmune Disorders, and Hematologic Malignant Neoplasms - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34106218/

This population-based cohort study identified associations between GA and baseline diabetes and hyperlipidemia as well as between GA and both baseline and incident autoimmune conditions. These findings suggest that diabetes...